SCHEMBL7192140

SCHEMBL7192140

CCOc1c(C=CC(=O)c2ccc(OC(=O)C(C)(C)C)cc2)cc(C(C)(C)C)c(OC(=O)C(C)(C)C)c1OC

nearest known ligand 0.48

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
CYP1A1 P04798 2/20 0.48
CYP1B1 Q16678 2/20 0.48
KDM4E B2RXH2 2/20 0.48
LMNA P02545 2/20 0.48
MAPT P10636 2/20 0.48
ALDH1A1 P00352 1/20 0.48
SMN1; SMN2 Q16637 1/20 0.48
TNFRSF1A P19438 2/20 0.47
DPP4 P27487 3/20 0.47
PTPN1 P18031 8/20 0.46
MAOB P27338 2/20 0.45
ABCG2 Q9UNQ0 2/20 0.42
IDH1 O75874 1/20 0.42
ABCB1 P08183 1/20 0.42
UGT1A1 P22309 1/20 0.42
ABCC1 P33527 1/20 0.42
PRMT6 Q96LA8 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7186217 0.92 CYP1A1 (0.47) CYP1A1CYP1B1KDM4ELMNAMAPT
SCHEMBL7186088 0.92 DPP4 (0.48) CYP1A1CYP1B1KDM4ELMNAMAPT
SCHEMBL7184167 0.92 TNFRSF1A (0.53) LMNAMAPTTNFRSF1ADPP4PTPN1
SCHEMBL7184544 0.91 PTPN1 (0.56) CYP1A1CYP1B1KDM4ELMNAMAPT
SCHEMBL7179053 0.90 PTPN1 (0.48) CYP1A1CYP1B1KDM4ELMNAMAPT
SCHEMBL7184708 0.90 CYP1A1 (0.48) CYP1A1CYP1B1KDM4ELMNAMAPT
SCHEMBL7186869 0.90 MAOB (0.46) CYP1A1CYP1B1KDM4ELMNAMAPT
SCHEMBL7186862 0.90 MAOB (0.46) CYP1A1CYP1B1KDM4ELMNAMAPT
SCHEMBL9269572 0.89 TNFRSF1A (0.47) KDM4ELMNAMAPTALDH1A1SMN1; SMN2
SCHEMBL7191627 0.88 CYP1A1 (0.47) CYP1A1CYP1B1KDM4ELMNAMAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6603046-B1 The invention is drawn to novel bis-aromatic a, beta -unsaturated ketones. The compounds are useful in the treatment and prophylaxis of diseases caused by parasites or bacteria. LICA PHARMACEUTICALS A/S (DK) 2003-08-05 US disclosed
EP-0634927-B1 TREATMENT AND PROPHYLAXIS OF DISEASES CAUSED BY PARASITES, OR BACTERIA LICA PHARMACEUTICALS AS (DK) 2001-07-04 EP disclosed
US-5985935-A PARASITICIDES OR BACTERICIDES STATENS SERUMINSTITUT (DK) 1999-11-16 US disclosed
EP-0634927-A1 TREATMENT AND PROPHYLAXIS OF DISEASES CAUSED BY PARASITES, OR BACTERIA STATENS SERUMINSTITUT (DK) 1995-01-25 EP disclosed
WO-1993017671-A1 TREATMENT AND PROPHYLAXIS OF DISEASES CAUSED BY PARASITES, OR BACTERIA STATENS SERUMINSTITUT (DK) 1993-09-16 WO disclosed